Unity Biotechnology (FRA:9U90) Accounts Payable : €1.63 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Unity Biotechnology Accounts Payable?

Unity Biotechnology's Accounts Payable for the quarter that ended in Sep. 2024 was €1.63 Mil.

Unity Biotechnology's quarterly Accounts Payable increased from Mar. 2024 (€1.29 Mil) to Jun. 2024 (€1.35 Mil) and increased from Jun. 2024 (€1.35 Mil) to Sep. 2024 (€1.63 Mil).

Unity Biotechnology's annual Accounts Payable declined from Dec. 2021 (€1.76 Mil) to Dec. 2022 (€1.69 Mil) and declined from Dec. 2022 (€1.69 Mil) to Dec. 2023 (€1.27 Mil).

Unity Biotechnology Accounts Payable Historical Data

The historical data trend for Unity Biotechnology's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unity Biotechnology Accounts Payable Chart

Unity Biotechnology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

4.67

2.10

1.76

1.69

1.27

Unity Biotechnology Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Payable	Get a 7-Day Free Trial															1.08	1.27	1.29	1.35	1.63

Unity Biotechnology Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Unity Biotechnology Accounts Payable Related Terms

Thank you for viewing the detailed overview of Unity Biotechnology's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Unity Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Unity Biotechnology Inc (FRA:9U90) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

UBX:USA 0YC0:UK 9U90:Germany

Address

285 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.unitybiotechnology.com

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Unity Biotechnology Headlines

No Headlines